feng rong li - Net Worth and Insider Trading
feng rong li Net Worth
The estimated net worth of feng rong li is at least $549,600 dollars as of 2024-11-11. feng rong li is the senior management of Shanghai Fosun Pharmaceutical (Group) Co Ltd and owns about 20,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) stock worth over $549,600. Details can be seen in feng rong li's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that feng rong li has not made any transactions after 2022-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of feng rong li
feng rong li Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, feng rong li owns 1 companies in total, including Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) .
Click here to see the complete history of feng rong li’s form 4 insider trades.
Insider Ownership Summary of feng rong li
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:600196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 2022-09-16 | senior management |
feng rong li Latest Holdings Summary
feng rong li currently owns a total of 1 stock. feng rong li owns 20,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) as of September 16, 2022, with a value of $549,600.
Latest Holdings of feng rong li
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:600196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 2022-09-16 | 20,000 | 27.48 | 549,600 |
Holding Weightings of feng rong li
feng rong li Form 4 Trading Tracker
According to the SEC Form 4 filings, feng rong li has made a total of 4 transactions in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Shanghai Fosun Pharmaceutical (Group) Co Ltd is the acquisition of 5,000 shares on September 16, 2022, which cost feng rong li around $161,150.
Insider Trading History of feng rong li
- 1
feng rong li Trading Performance
GuruFocus tracks the stock performance after each of feng rong li's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by feng rong li is 14.02%. GuruFocus also compares feng rong li's trading performance to market benchmark return within the same time period. The performance of stocks bought by feng rong li within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how feng rong li's insider trading performs compared to the benchmark.
Performance of feng rong li
feng rong li Ownership Network
Ownership Network List of feng rong li
Ownership Network Relation of feng rong li
feng rong li Owned Company Details
What does Shanghai Fosun Pharmaceutical (Group) Co Ltd do?
Who are the key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd?
feng rong li is the senior management of Shanghai Fosun Pharmaceutical (Group) Co Ltd. Other key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd include Directors & senior managers wen de yong , senior management bao qin gui , and senior management Mei Jing Ping .
Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) Insider Trades Summary
Over the past 18 months, feng rong li made no insider transaction in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196). Other recent insider transactions involving Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) include a net sale of 0 shares made by Wu Yi Fang , a net sale of 0 shares made by Wang Ke Xin , and a net sale of 0 shares made by wen de yong .
In summary, during the past 3 months, insiders sold 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions
feng rong li Mailing Address
Above is the net worth, insider trading, and ownership report for feng rong li. Currently GuruFocus does not have mailing address information for feng rong li.